About Precision Medical Ventures, Inc. Dba Revealdx
RevealDx is a Seattle-based medical imaging software company whose mission is to dramatically improve lung cancer outcomes through non-invasive diagnosis. The company has developed RevealAI-Lung, an FDA-cleared, AI-powered decision support tool that characterizes incidental lung nodules found on chest CT scans. Using proprietary radiomics and ensemble AI techniques, RevealDx produces a Malignancy Similarity Index (mSI) score that helps clinicians assess cancer risk and make more informed treatment decisions. The technology employs a patented approach that provides improved stability across image types and allows for transparency of predictions. It extracts local predictive value from three-dimensional analysis of lesions, then enhances results using broader lung and chest analysis. Ensemble classification techniques are coupled with layers of radiomic features to provide depth of analysis, converging more quickly on accurate predictive values than CNNs alone. RevealAI-Lung integrates directly with PACS systems via single-click operation, displaying results within seconds. The solution aims to reduce unnecessary procedures, lower healthcare costs, and enable earlier cancer detection. RevealDx has validated its software on over 1,500 patients from various cohorts and the product is now reimbursable by Medicare using CPT codes 0721T and 0722T. The company serves radiologists, health systems, and healthcare providers focused on improving lung nodule management workflows.
Mission & Story
Mission
RevealDx's mission is to dramatically improve lung cancer outcomes using non-invasive diagnosis
Founding Story
RevealDx is a young company started in early 2021. The company jump-started operations by purchasing the assets of Mindshare Medical in March 2021. Mindshare had invested significantly over 5 years developing core patented algorithms, validating clinical performance, and structuring regulatory and user workflows for rapid adoption. The founder is Michael Calhoun, PhD, a serial innovator in imaging science and technology who previously founded Mindshare Medical.
Clinical Focus
Medical conditions and clinical areas addressed by Precision Medical Ventures, Inc. Dba Revealdx.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance received February 2026. CE Mark (MDR) certification received November 2025. Partnership with Azra AI announced May 2026. Medicare reimbursement codes established (0721T and 0722T).
Key Partnerships
Social & Media
Latest Updates
RevealDx Receives FDA Clearance for AI Powered Lung Nodule Risk Assessment
Azra and RevealDx Announce Partnership
Sirona Medical partners with RevealDx to transform lung cancer screening with a comprehensive suite of reimbursed AI tools
Royal United Hospitals Bath NHS Foundation Trust and RevealDx Announce the Completion of an Evaluation of RevealAI-Lung on High Risk Patients
RevealDx and Riverain Technologies Partner to Improve Lung Cancer Detection with mSI Malignancy Scoring
Company Details
- Founded
- 2021
- Headquarters
- Seattle, WA, USA
- Employees
- 1-10
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.